中肽生化目录肽版块全新呈现，致力于打造全球最全面的多肽供应平台！我们专业的学术团队将时刻追踪最新最热的研究动向，帮助您发现实际需求，并以最高质量标准提供您所需要的产品。我们将我们将不定期更新产品列表，为您最大限度地节约科研时间，敬请广大客户朋友关注！
CANS-012A
Pep-1L-NOTA
H-Ala-Cys-Gly-Glu-Met-Gly-Trp-Val-Arg-Cys-Gly-Gly-Gly-Ser-C6-Lys-Lys(NOTA)-NH2 (trifluoroacetate salt) (Reduced Cys-H)
H-Ala-Cys-Gly-Glu-Met-Gly-Trp-Val-Arg-Cys-Gly-Gly-Gly-Ser-C6-Lys-Lys(NOTA)-NH2 (trifluoroacetate salt) (Reduced Cys-H)
Size：1.0mg
P1(RMB)：2380
MW：2023.36
One letter sequence：ACGEMGWVRCGGGS-C6-K-K(NOTA)-NH2
Molecular Formula：C84H139N27O25S3
Description：Metal chelating peptide Pep-1L-NOTA targets tumor-restricted receptor, IL13RA2, found to be present in some aggressive malignancies, specifically gliomas and malignant melanoma. Recent work has demonstrated that the copper-bound peptide selectively binds hIL13RA2-expressing tumors and validates its use in peptide-based PET imaging for cancer diagnostics.
Literature Reference：Sai, Kiran Kumar Solingapuram, et al. "Peptide-based PET imaging of the tumor restricted IL13RA2 biomarker." Oncotarget 5 (2017).
Cas：
P1(RMB)：2380
MW：2023.36
One letter sequence：ACGEMGWVRCGGGS-C6-K-K(NOTA)-NH2
Molecular Formula：C84H139N27O25S3
Description：Metal chelating peptide Pep-1L-NOTA targets tumor-restricted receptor, IL13RA2, found to be present in some aggressive malignancies, specifically gliomas and malignant melanoma. Recent work has demonstrated that the copper-bound peptide selectively binds hIL13RA2-expressing tumors and validates its use in peptide-based PET imaging for cancer diagnostics.
Literature Reference：Sai, Kiran Kumar Solingapuram, et al. "Peptide-based PET imaging of the tumor restricted IL13RA2 biomarker." Oncotarget 5 (2017).
Cas：
